Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lifordi Immunotherapeutics, Inc.

Clinical trials sponsored by Lifordi Immunotherapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New RA drug LFD-200 enters early human testing Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New RA drug LFD-200 enters early human testing

Symptom relief Recruiting now

This early-stage study tests a new drug called LFD-200 in healthy volunteers and people with moderate to severe rheumatoid arthritis (RA). The main goal is to check safety and how the body processes the drug. Researchers will give single or multiple doses and watch for side effec…

Phase 1 • Sponsor: Lifordi Immunotherapeutics, Inc. • Aim: Symptom relief

Last updated Jul 30, 2026 00:00 UTC